Complex management of GS (Good's syndrome) with persistent COVID-19 infection and polymicrobial infections: A case report

This case report highlights the diagnostic and therapeutic complexities faced by a 56-year-old female with Good's syndrome (GS), who presented with persistent Coronavirus Disease 2019 (COVID-19) infection alongside <i>Aspergillus</i> spp, <i>cytomegalovirus</i>, and <i>Pseudomonas aeruginosa</i> co-infection, which collectively contributed to severe pulmonary involvement. The report further emphasizes a multifaceted treatment approach, incorporating antivirals, antifungals, antimicrobials, immunoglobulins, and antifibrotic therapy, which ultimately led to an improvement in the patient's condition. It underscored the intricate challenges of managing immunocompromised patients with multiple concurrent infections. The detailed diagnosis and treatment process of this complex case provides valuable insights to clinicians managing similar scenarios.